Richard Lacombe
Keine laufenden Positionen mehr
Profil
Richard Lacombe served as President & Chief Executive Officer at Virocell, Inc. from 2002 to 2004.
He was also the GM-Asia Pacific, Canada & Latin America at Covance (Canada), Inc. from 2000 to 2002.
He served as Vice President-Clinical Affairs at BioSyntech, Inc. from 2006 to 2008 and as Director at LAB Research, Inc. from 2006 to 2009.
He was also a Director at Warnex, Inc. Dr. Lacombe holds a doctorate from the University of Montréal and an MBA from the University of Sherbrooke.
Ehemalige bekannte Positionen von Richard Lacombe
Unternehmen | Position | Ende |
---|---|---|
LAB Research, Inc.
LAB Research, Inc. Miscellaneous Commercial ServicesCommercial Services LAB Research, Inc. provides in-vivo non-clinical research services for the global pharmaceutical, biotechnology, agrochemical and petro-chemical industries. The company performs pre-clinical studies required for the development of drugs used in the treatment of human conditions or diseases. It offers pre-Phase I, pre-Phase II/III and other services. The company's pre-Phase I services include general toxicology, genotoxicity, safety pharmacology, bioanalytics and efficacy studies. Its pre-Phase II/III services include reproductive toxicology, carcinogenicity and absorption, distribution, metabolism and excretion studies. The company was founded in 1998 and is headquartered in Laval, Canada. | Direktor/Vorstandsmitglied | 16.12.2009 |
BIOSYNTECH, INC. | Technik-/Wissenschafts-/F&E-Leiter | 31.12.2008 |
Virocell, Inc. | Präsident | 01.02.2004 |
Covance (Canada), Inc. | Corporate Officer/Principal | 01.04.2002 |
WARNEX INC. | Direktor/Vorstandsmitglied | - |
Ausbildung von Richard Lacombe
University of Montréal | Doctorate Degree |
University of Sherbrooke | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
BIOSYNTECH, INC. | Health Technology |
Private Unternehmen | 4 |
---|---|
Warnex, Inc.
Warnex, Inc. Medical SpecialtiesHealth Technology Warnex, Inc. engages as a life sciences company devoted to protecting public health by providing laboratory services to the pharmaceutical sector. The company was founded on January 4, 1996 and is headquartered in Laval, Canada. | Health Technology |
LAB Research, Inc.
LAB Research, Inc. Miscellaneous Commercial ServicesCommercial Services LAB Research, Inc. provides in-vivo non-clinical research services for the global pharmaceutical, biotechnology, agrochemical and petro-chemical industries. The company performs pre-clinical studies required for the development of drugs used in the treatment of human conditions or diseases. It offers pre-Phase I, pre-Phase II/III and other services. The company's pre-Phase I services include general toxicology, genotoxicity, safety pharmacology, bioanalytics and efficacy studies. Its pre-Phase II/III services include reproductive toxicology, carcinogenicity and absorption, distribution, metabolism and excretion studies. The company was founded in 1998 and is headquartered in Laval, Canada. | Commercial Services |
Virocell, Inc. | |
Covance (Canada), Inc. |